Dissecting the regulatory network of transcription factors in T cell phenotype/functioning during GVHD and GVT
- PMID: 37441063
- PMCID: PMC10333690
- DOI: 10.3389/fimmu.2023.1194984
Dissecting the regulatory network of transcription factors in T cell phenotype/functioning during GVHD and GVT
Abstract
Transcription factors play a major role in regulation and orchestration of immune responses. The immunological context of the response can alter the regulatory networks required for proper functioning. While these networks have been well-studied in canonical immune contexts like infection, the transcription factor landscape during alloactivation remains unclear. This review addresses how transcription factors contribute to the functioning of mature alloactivated T cells. This review will also examine how these factors form a regulatory network to control alloresponses, with a focus specifically on those factors expressed by and controlling activity of T cells of the various subsets involved in graft-versus-host disease (GVHD) and graft-versus-tumor (GVT) responses.
Keywords: GVHD; GVL; allotransplantation; regulatory networks; transcription factors.
Copyright © 2023 Harris and Karimi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice.J Immunol. 2015 Feb 1;194(3):1011-20. doi: 10.4049/jimmunol.1303099. Epub 2014 Dec 19. J Immunol. 2015. PMID: 25527786 Free PMC article.
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
-
The complex and central role of interferon-γ in graft-versus-host disease and graft-versus-tumor activity.Immunol Rev. 2014 Mar;258(1):30-44. doi: 10.1111/imr.12151. Immunol Rev. 2014. PMID: 24517424 Free PMC article. Review.
-
The anti-tumor effect of allogeneic bone marrow/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement?Med Hypotheses. 2008;70(6):1186-92. doi: 10.1016/j.mehy.2007.10.008. Epub 2007 Dec 3. Med Hypotheses. 2008. PMID: 18054441
-
Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.Leuk Lymphoma. 2000 Jul;38(3-4):221-34. doi: 10.3109/10428190009087014. Leuk Lymphoma. 2000. PMID: 10830730 Review.
Cited by
-
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation.Cells. 2024 Jan 11;13(2):134. doi: 10.3390/cells13020134. Cells. 2024. PMID: 38247827 Free PMC article. Review.
-
Deep insight into cytokine storm: from pathogenesis to treatment.Signal Transduct Target Ther. 2025 Apr 16;10(1):112. doi: 10.1038/s41392-025-02178-y. Signal Transduct Target Ther. 2025. PMID: 40234407 Free PMC article. Review.
-
The Impact of Cell-Intrinsic STAT6 Protein on Donor T Cell-Mediated Graft-Versus-Tumor Effect.Int J Mol Sci. 2024 Dec 31;26(1):280. doi: 10.3390/ijms26010280. Int J Mol Sci. 2024. PMID: 39796136 Free PMC article.
References
-
- Foster AE, Marangolo M, Sartor MM, Alexander SI, Hu M, Bradstock KF, et al. . Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion. Blood (2004) 104:2403–9. doi: 10.1182/blood-2003-12-4431 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical